Lutz G Gurtler

Title: Lutz G Gurtler: Innovator in Retroviral Research

Introduction

Lutz G Gurtler is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of immunodeficiency viruses, particularly through his innovative research and patents. With a total of 2 patents, Gurtler's work has advanced the understanding of retroviruses associated with immunodeficiency diseases.

Latest Patents

Gurtler's latest patents include groundbreaking work on retroviruses from the HIV group. One of his notable patents is for a novel immunodeficiency virus designated MVP-2901/94. This virus has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 95012601. The patent discloses characteristic antigens that can be obtained from the virus, which are essential for detecting antibodies against retroviruses linked to immunodeficiency diseases. Additionally, Gurtler has developed a patent for a retrovirus from the HIV type O, also designated MVP-2901/94, which shares similar characteristics and applications.

Career Highlights

Lutz G Gurtler is associated with Behringwerke Aktiengesellschaft, where he has been instrumental in advancing research in retroviral diseases. His work has not only contributed to scientific knowledge but has also paved the way for potential therapeutic applications.

Collaborations

Gurtler has collaborated with notable colleagues in his field, including Hans-Peter Hauser and Stefan Knapp. These collaborations have further enriched his research and contributed to the development of innovative solutions in retroviral research.

Conclusion

Lutz G Gurtler's contributions to the field of immunodeficiency viruses through his patents and research have made a significant impact. His work continues to influence the understanding and detection of retroviruses, showcasing the importance of innovation in medical science.